Location History:
- Vancouver, CA (2015)
- Saskatoon, CA (2019 - 2022)
Company Filing History:
3 out of 213 
2 out of 932 
Years Active: 2015-2022
Title: Changiz Taghibiglou: Innovator in Biomedical Research
Introduction
Changiz Taghibiglou is a prominent inventor based in Saskatoon, Canada. He has made significant contributions to the field of biomedical research, particularly in the detection and treatment of brain injuries and skin conditions. With a total of 5 patents, his work has the potential to impact many lives.
Latest Patents
One of his latest patents involves the use of ADAM-10 as a biomarker for detecting brain injury. This method allows for the detection of brain injuries by comparing the amount of ADAM10 protein in a blood sample from a subject to a reference standard. An increase in ADAM10 levels indicates that the subject may have sustained a traumatic brain injury (TBI). Additionally, he has developed polypeptides and antibodies aimed at treating skin conditions associated with the overproduction of sebum, such as acne and seborrhea. These compositions and methods focus on inhibiting insig-1 ubiquitination to prevent or treat these skin diseases.
Career Highlights
Changiz has worked at esteemed institutions such as the University of Saskatchewan and the University of British Columbia. His research has garnered attention for its innovative approaches to pressing medical issues.
Collaborations
Throughout his career, Changiz has collaborated with notable colleagues, including Yu Tian Wang and Shu Zhang. Their combined expertise has contributed to the advancement of their research projects.
Conclusion
Changiz Taghibiglou stands out as an influential inventor in the biomedical field. His innovative patents and research efforts continue to pave the way for advancements in medical diagnostics and treatments.